EP1581551A4 - Antagonistes du récepteur de f11 (f11r) en tant qu'agents thérapeutiques - Google Patents
Antagonistes du récepteur de f11 (f11r) en tant qu'agents thérapeutiquesInfo
- Publication number
- EP1581551A4 EP1581551A4 EP03815213A EP03815213A EP1581551A4 EP 1581551 A4 EP1581551 A4 EP 1581551A4 EP 03815213 A EP03815213 A EP 03815213A EP 03815213 A EP03815213 A EP 03815213A EP 1581551 A4 EP1581551 A4 EP 1581551A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antagonists
- receptor
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43866903P | 2003-01-03 | 2003-01-03 | |
US438669P | 2003-01-03 | ||
PCT/US2003/039890 WO2004063327A2 (fr) | 2003-01-03 | 2003-12-16 | Antagonistes du recepteur de f11 (f11r) en tant qu'agents therapeutiques |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1581551A2 EP1581551A2 (fr) | 2005-10-05 |
EP1581551A4 true EP1581551A4 (fr) | 2007-12-12 |
Family
ID=32713364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03815213A Withdrawn EP1581551A4 (fr) | 2003-01-03 | 2003-12-16 | Antagonistes du récepteur de f11 (f11r) en tant qu'agents thérapeutiques |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1581551A4 (fr) |
JP (1) | JP2006516255A (fr) |
AU (1) | AU2003297124A1 (fr) |
CA (1) | CA2512399A1 (fr) |
WO (1) | WO2004063327A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050265992A1 (en) | 2003-01-03 | 2005-12-01 | The Research Foundation Of State University Of New York | F11 receptor (F11R) antagonists as therapeutic agents |
US8557957B2 (en) | 2003-01-03 | 2013-10-15 | Elizabeth Kornecki | Methods of treating disorders by administration of F11 receptor antagonists |
WO2020256795A1 (fr) * | 2019-06-19 | 2020-12-24 | The Research Foundation For The State University Of New York | Procédés de traitement de l'hyperplasie néointimale au moyen d'inhibiteurs de f11r/jam-a |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5665701A (en) * | 1994-11-17 | 1997-09-09 | The Research Foundation Of State University Of New York | Platelet membrane glycoprotein F11 and polypeptide fragments thereof |
WO1999002561A1 (fr) * | 1997-07-10 | 1999-01-21 | Smithkline Beecham Corporation | Antigene f11 humain, constituant un recepteur de surface cellulaire implique dans l'agregation plaquettaire |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6699688B1 (en) * | 1998-09-16 | 2004-03-02 | The Research Foundation Of The State University Of New York | Human platelet F11 receptor |
-
2003
- 2003-12-16 EP EP03815213A patent/EP1581551A4/fr not_active Withdrawn
- 2003-12-16 JP JP2004566554A patent/JP2006516255A/ja active Pending
- 2003-12-16 CA CA002512399A patent/CA2512399A1/fr not_active Abandoned
- 2003-12-16 AU AU2003297124A patent/AU2003297124A1/en not_active Abandoned
- 2003-12-16 WO PCT/US2003/039890 patent/WO2004063327A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5665701A (en) * | 1994-11-17 | 1997-09-09 | The Research Foundation Of State University Of New York | Platelet membrane glycoprotein F11 and polypeptide fragments thereof |
WO1999002561A1 (fr) * | 1997-07-10 | 1999-01-21 | Smithkline Beecham Corporation | Antigene f11 humain, constituant un recepteur de surface cellulaire implique dans l'agregation plaquettaire |
Non-Patent Citations (2)
Title |
---|
BABINSKA ANNA ET AL: "Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion", THROMBOSIS AND HAEMOSTASIS, vol. 87, no. 4, April 2002 (2002-04-01), pages 712 - 721, XP002456220, ISSN: 0340-6245 * |
SOBOCKA MALGORZATA B ET AL: "Cloning of the human platelet F11 receptor: A cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation", BLOOD, vol. 95, no. 8, 15 April 2000 (2000-04-15), pages 2600 - 2609, XP002456219, ISSN: 0006-4971 * |
Also Published As
Publication number | Publication date |
---|---|
EP1581551A2 (fr) | 2005-10-05 |
WO2004063327A3 (fr) | 2005-04-21 |
AU2003297124A1 (en) | 2004-08-10 |
WO2004063327A2 (fr) | 2004-07-29 |
CA2512399A1 (fr) | 2004-07-29 |
AU2003297124A8 (en) | 2004-08-10 |
JP2006516255A (ja) | 2006-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0303910D0 (en) | Therapeutic agents | |
GB0308318D0 (en) | Therapeutic agents | |
GB0314079D0 (en) | Therapeutic agents | |
GB0314057D0 (en) | Therapeutic agents | |
IL173746A0 (en) | Modified il-4 mutein receptor antagonists | |
GB0313250D0 (en) | Therapeutic agents | |
GB0314049D0 (en) | Therapeutic agents | |
GB0314129D0 (en) | Therapeutic agents | |
AU2003267088A8 (en) | Chemokine receptor antagonists as therapeutic agents | |
GB0311859D0 (en) | Therapeutic agents | |
GB0311201D0 (en) | Therapeutic agents | |
GB0301350D0 (en) | Therapeutic agents | |
IL173337A0 (en) | Receptor | |
AU2003297124A8 (en) | F11 receptor(f11r) antagonists as therapeutic agents | |
EP1915388A4 (fr) | Utilisation d'antagonistes du recepteur f11 receptor (f11r) comme agents therapeutiques | |
GB0304524D0 (en) | Therapeutic agents | |
GB0314075D0 (en) | Therapeutic agents | |
GB0314131D0 (en) | Therapeutic agents | |
GB0314078D0 (en) | Therapeutic agents | |
GB0321998D0 (en) | Receptor | |
GB0315252D0 (en) | Receptor proteins | |
GB0220459D0 (en) | Receptor proteins | |
GB0223877D0 (en) | Receptor proteins | |
GB0307100D0 (en) | Receptor | |
GB0329104D0 (en) | Receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050704 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20071108 |
|
17Q | First examination report despatched |
Effective date: 20090302 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110927 |